Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06434194 · ClinicalTrials.gov registry record · NA
Serrantor OCT Study
A NA study of Critical Limb Ischemia, sponsored by Cagent Vascular.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT06434194 is a NA study of Critical Limb Ischemia that is actively recruiting participants, run by Cagent Vascular. The registered enrollment target is 60 participants, below the 88-participant average among 18 other Critical Limb Ischemia trials with a reported enrollment target (32% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06434194, a NA study of Critical Limb Ischemia, is actively recruiting participants, sponsored by Cagent Vascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.
Conditions Studied
Interventions
- DEVICE Serranator PTA Serration Catheter
- DRUG PTA (Standard of Care)
Study Locations (2)
New York
- Columbia University - New York
- Weill Cornell Medical - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06434194
The ClinicalTrials.gov registry entry for NCT06434194 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 88-participant average among 18 other Critical Limb Ischemia trials with a reported enrollment target (32% lower). The listed sponsor is Cagent Vascular, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Critical Limb Ischemia appearing as the primary indexed condition, and to 2 interventions - of which Serranator PTA Serration Catheter is the first listed.
NCT06434194 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06434194 about?
NCT06434194 is a clinical study titled "Serrantor OCT Study". TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.
What is the current status of trial NCT06434194?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-10-31. Estimated completion is 2025-06-01.
What conditions does trial NCT06434194 study?
This clinical trial studies the following conditions: Critical Limb Ischemia.
What interventions are being tested in trial NCT06434194?
The interventions under investigation include: Serranator PTA Serration Catheter (DEVICE), PTA (Standard of Care) (DRUG).
Who is sponsoring clinical trial NCT06434194?
This trial is sponsored by Cagent Vascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06434194 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Limb Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MOTIV BTK Randomized Controlled Trial
RECRUITING · NA
-
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
RECRUITING · NA
-
Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
COMPLETED · NA
-
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
COMPLETED · NA
-
BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI
COMPLETED · NA
-
PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.